The mammalian ovulatory process is a fairly complex succession of events that leads to the release of a competent oocyte. The luteinizing hormone (LH) triggers the cascade of events, which starts with the production of secondary messengers in the follicular wall and ends with the release of a fertilizable oocyte. Most of these events can be reproduced using in vitro models, which offer a wide range of possibilities for study strategies. Although it is accepted that epidermal growth factor receptor (EGFR) activation is required for transmission of the LH-initiated signal, we hypothesized that LH receptor activation might also play a role in oocyte meiotic resumption and cumulus cell response, because the current mouse preantral follicle in vitro model expresses functional LH receptor. To separate the LH-mediated response and the epidermal growth factor (EGF)-mediated response (following LH stimulus), in vitro-grown mouse ovarian follicles were stimulated for ovulation with a combination of human chorionic gonadotropin (hCG) plus galardin (inhibitor for the release of endogenous EGF-like factors) or hCG plus galardin plus EGF. Results suggest that the stimulation provided by LH (hCG) is insufficient to induce a maximum oocyte meiotic resumption and that EGFR activation is also required. Analysis of transcript levels of Egfr, Ereg, Cyp19a1, Hsd3b1, Adamts1, and Has2 in cumulus cells further indicate that the triggers for the EGFR cascade preserve the expression profile of the studied transcripts. Therefore, it is proposed that within this in vitro mouse model, EGF signaling during ovulation might protect the cumulus cells from the potential luteinizing effects of LH.
INTRODUCTION
Throughout ovarian follicular development, granulosa cells differentiate into two compartments: those in direct contact with the oocyte (the cumulus cells) and the mural granulosa cells forming part of the follicular wall. Compared to mural cells, cumulus cells are less steroidogenic, and they mucify and expand after the ovulatory stimulus [1] [2] [3] [4] [5] . Previously, the ability of cumulus cells to undergo mucification and expansion during the ovulatory process has been attributed to the presence of autocrine and/or paracrine factors produced within the follicle [6, 7] . The luteinizing hormone (LH) ovulatory peak induces the production and shedding of membrane-bound, epidermal growth factor (EGF)-like factors from mural granulosa cells. Within 3 h after the LH ovulatory stimulus, expression of the EGF-like factors epiregulin, beta-cellulin, and amphiregulin is up-regulated in mural granulosa cells of preovulatory follicles [8, 9] . These factors are the endogenous messengers of LH action within the ovarian follicle. More specifically, amphiregulin has been shown to induce expression of genes related to mucification and expansion of cumulus cells (Ptgs2, Has2, and Tnfaip6) and steroidogenesis (Star and Cyp11a1) [10] . Pioneering studies on EGF-like factors in the ovary have shown that they also activate oocyte meiotic resumption [8] , and subsequent work has demonstrated the interplay of other linked processes in granulosa cells and oocytes (i.e., LH-induced drop in cGMP in granulosa cells and oocyte and increase in the activity of phosphodiesterase type 3A) [11] . All of the above-mentioned periovulatory events can be reproduced in vitro by administration of EGF, as has been demonstrated by Downs et al. [12] , Downs [13] , De La Fuente et al. [14] , and Diaz et al. [5] and in the current mouse in vitro culture model [15] .
Another role for EGF relates to regulation of steroidogenesis in the growing and ovulatory follicle. Almahbobi et al [16] reported that EGF or transforming growth factor alpha blocked mouse antral follicle growth and reduced estradiol production within the follicle. The precise effects of EGF on the luteinization-related steroidogenesis are still unclear, because reports have provided contradictory data on EGF-induced progesterone production [15, 17] .
Evidence indicates that LH is able to transactivate the EGF receptor (EGFR), by which an immediate response is generated, even before the endogenous EGF-like factors are released [18] . Because in vivo LH receptors are absent or expressed at very low levels on cumulus cells [19] [20] [21] , it remains a matter of discussion whether LH (or human chorionic gonadotropin [hCG]) might exert a direct action on these cells rather than play a limited complementary effect.
Recent work from our group has demonstrated that small, near-physiological changes in hormonal conditions affect gene expression of key factors in cumulus cells and oocytes [22] . For instance, the expression of the LH/choriogonadotropin receptor (LHCGR) in granulosa cells, being a key regulator of a multitude of processes in the follicle (for review, see Richards [23] ), can be altered in localization and quantity by culture conditions; as an example, the regulation of LHCGR expression in cumulus cells has been shown to be dependent on the presence of oocyte-secreted factors and/or the folliclestimulating hormone (FSH) dosage [5, 19, 22] . Consequently, the cascade downstream of the LH receptor activation in mural granulosa and cumulus cells, involving the EGF-like factors, is an obvious focus of analysis to improve the results of follicle culture. The aims of current study were to evaluate the response triggered by the activation of both LHCGR and EGFR on both oocyte meiotic resumption and the gene expression profile of cumulus cells during the early luteinization process in a mouse model for in vitro follicle culture.
MATERIALS AND METHODS

Animal Model
Animals used for these experiments were housed and bred following the national legislation of Belgium and with the consent of the ethical committee of the Vrije Universiteit Brussel (Project 05-395-2).
Follicle Culture
Ovarian follicles from 13-day-old mice (F 1 hybrids: C57Bl/6j 3 CBA/ca) were mechanically isolated and cultured as described by Cortvrindt and Smitz [24] . Briefly, once the ovaries were retrieved from the abdominal cavity, preantral follicles were dissected out in Leibovitz L-15, containing 10% heatinactivated fetal bovine serum (FBS), 100 IU/ml of penicillin, and 100 lg/ml of streptomycin (Penicillin/Streptomycin-Mix; all from Invitrogen). Only follicles with diameters between 110 and 130 lm were individually transferred to 96-well microtiter plates (Costar, Elscolab) in setup medium containing 75 ll of aMinimum Essential Medium GlutaMAX and 5% FBS (both from Invitrogen), with 5 ng/ml of insulin, 5 lg/ml of Apo-Transferrin, and 5 ng/ml of sodium selenite (all from Sigma) as well as 10 mIU/ml of recombinant FSH (rFSH) and 10 mIU/ml of recombinant LH (rLH) (both from Ares-Serono). The culture was carried out for 13 days at 378C, 5% CO 2, and 100% humidity. Refreshment of medium was done every 4 days by replacing 30 ll of spent medium with a refreshment medium similar to setup medium but without rLH.
Ovulatory Stimulus
The aim of the present study was to assess the effects of hCG (with or without the additional helping effect of EGF) on both oocyte meiotic resumption and the gene expression profile of the corresponding cumulus cells during early follicle luteinization (up to 16 h after the ovulatory stimulus). Given that activation of the LH receptor on the mural granulosa cells signals cumulus cells via the EGF-like factors, a broad-spectrum inhibitor of metalloproteinases (galardin; Biomol International) was concomitantly used with the hCG stimulus. Galardin reduces the release of EGF-like factors from the cell membrane and causes reduced signaling via the EGFRs at doses of 10 and 20 lM in porcine and rodents [9, 10, 17, 18] . In vitro hCG administration was used to reproduce the LH ovulatory effects.
On Culture Day 12 (time, 0 h), the fully grown ovarian follicles were exposed to two stimulatory treatments: 1.2 IU hCG plus 10 lM galardin (hCG þ galardin) or 1.2 IU hCG plus 10 lM galardin plus 4 ng/ml of EGF (hCG þ galardin þ EGF) using recombinant hCG (rhCG; Ares-Serono) and recombinant EGF (rEGF; Roche). Addition of EGF to the latter treatment was intended to compensate for the galardin-induced block on the endogenous EGF-like factors. As an in vitro control for nonspecific adverse (or toxic) effects caused by galardin, fully grown follicles were also exposed for 16 h to hCG plus EGF (without galardin). Similar concentrations of hCG and EGF have been previously shown to induce maximum meiotic resumption in cultured follicles [25] . Refer to Figure 1 for a detailed experimental setup.
Additionally, a different inhibitor of EGF signaling (0.5 lM AG1478; Calbiochem-Merck) was also used to abolish EGF effects. In contrast to galardin, AG1478 is a specific inhibitor of the EGFR tyrosine kinase.
Effect of Ovulatory Stimulus on Mucification/Expansion of Cumulus Cells and Follicular Progesterone Production
Cumulus-oocyte complexes (COCs) were observed under a stereomicroscope, and the mucification/expansion was assessed at 2, 4, 8, 12, and 16 h after the stimulation with hCG þ galardin or hCG þ galardin þ EGF and at 16 h for the control treatment of hCG plus EGF without galardin.
Spent medium was pooled per six or seven follicles (30 ll each) and collected at the same time points for further analysis of progesterone production by direct radioimmunoassay (Cisbio International). At least eight samples per condition and per time point were analyzed.
Oocyte Meiotic Maturation and Cumulus Cell Collection
At the previously specified time points after the ovulatory stimulus, oocytes were mechanically freed from cumulus cells using a mouth-controlled, fine-bore, glass pipette. Oocyte meiotic resumption was analyzed by assessing the nuclear maturational stage under an inverted microscope equipped with a Hoffman modulation contrast system (Nikon). Nuclear maturation was scored as GV (germinal vesicle stage), GVBD (when GV breakdown was initiated), and PB (when the first polar body was extruded), and cumulus cells from four to eight follicles were pooled and snap-frozen for assessment of gene expression.
Data were generated from at least four biological replicates, with each replicate representing 12-14 follicles per time point/treatment. For the additional experiment with hCG plus AG1478, four biological replicates were used, with at least 28 oocytes per time point.
Collection of In Vivo Controls
Pools of cumulus cells from five to seven COCs were collected from adult female mice (age, 8-12 wk) at 48 h after injection of 5 IU of equine chorionic gonadotropin (eCG; Folligon; Intervet) and at 14 h after the ovulatory stimulus with 5 IU hCG (Chorulon; Intervet) injection 48 h after the eCG injection. These conditions are referred to hereafter as in vivo pre-and post-hCG.
Gene Expression in Cumulus Cells of Stimulated Follicles
RNA isolation and cDNA synthesis.Total RNA was extracted from five or six pools of cumulus cells of in vivo-and in vitro-grown follicles (at specified time points) using the RNeasy Micro Kit (Qiagen) according to manufacturer's instructions, including a DNase step. Extracted mRNA was eluted in 14 ll of RNase-free water.
Total mRNA was reverse transcribed to cDNA using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories) containing blend oligo(dT) and random primers according to manufacturer's instructions.
Real-time PCR. Complementary DNA quantification by real-time PCR was performed on a LightCycler 480 apparatus (Roche Diagnostics). Primers sequences for mouse EGFR (Egfr), epiregulin (Ereg), P450 aromatase (Cyp19a1), 3-beta-hydroxysteroid dehydrogenase (Hsd3b1), disintegrin and metalloproteinase with thrombospondin motifs 1 (Adamts1), and hyaluronan synthase 2 (Has2) are detailed in Table 1 .
The total volume for the amplification reaction was 15 ll, containing 2 ll of cDNA, 7.5 ll of SYBR Green PCR Master Mix 2x (Roche Diagnostics), and 0.6 lM primer mix. The amplification cycle was as follows: 958C for 10 min, followed by 55 cycles of 958C for 10 sec and 608C for 30 sec. Primer specificity was ascertained by acquisition of the melting curve. Quantification of gene-specific transcripts was calculated on the basis of the standard curve generated by amplification of serial dilutions of gene-specific amplicons. To guarantee the specificity of the PCR products, the melting curves after amplification cycle were analyzed. All transcript levels were normalized to the content of 18S ribosomal RNA.
Statistical Analysis
Comparisons of the nuclear meiotic stages among the conditions were done after arcsine conversion of the percentages of nuclear meiotic stages for each treatment. Significant differences for oocyte meiotic resumption, at assessed time points, were obtained by one-way ANOVA followed by a Tukey posttest. Significant differences for gene expression data over time also were obtained by one-way ANOVA followed by a Tukey posttest.
Two independent one-way ANOVAs were performed to compare the different time points after stimulation with hCG þ galardin and with hCG þ galardin þ EGF. Significant differences in transcript levels at 16 h among the conditions hCG þ galardin, hCG þ galardin þ EGF, control (hCG plus EGF without galardin), and post-hCG in vivo control were also assessed using oneway ANOVA followed by Tukey posttest. Additionally, the same analysis was performed to assess the pattern of gene expression after treatment with hCG plus AG1478.
Comparisons of gene expression for both experimental treatments (hCG þ galardin and hCG þ galardin þ EGF) at a specific time point were performed with t-test. Comparison of gene expression at 0 h between in vitro and in vivo controls was also performed with t-test.
Statistical analyses were performed using GraphPad Prism 4.00 for Windows (GraphPad Software).
RESULTS
Effect of Ovulatory Stimulus on Mucification/Expansion of Cumulus Cells and Follicular Progesterone Production
Given that morphological assessment of the cumulus expansion is a rather subjective assessment, no strong EGF EFFECT ON COCS OF IN VITRO-CULTURED FOLLICLES conclusions were made on this matter. Overall mucification/ expansion of cumulus cells was more abundant in follicles stimulated with hCG þ galardin þ EGF compared to those stimulated with hCG þ galardin.
Progesterone production was induced by both ovulatory stimuli with a similar pattern ( Table 2) . Progesterone concentration in medium before administration of stimuli (Day 12; time, 0 h) was on average 2 lg/L and increased from 2 h onward, reaching approximately 200 lg/L by 16 h after the ovulation trigger.
Oocyte Meiotic Maturation
Oocyte meiotic resumption was assessed at 2, 4, 8, 12, and 16 h after stimulus. Before 8 h, no differences were observed between the hCG þ galardin and hCG þ galardin þ EGF groups; therefore, only relevant results (8, 12 , and 16 h) are shown (Fig. 2) . For every time point, a significantly lower GVBD rate was observed when the release of the EGF-like factors was blocked by galardin. By 16 h, only 46% of the oocytes in the hCG þ galardin group reached the GVBD stage, whereas 100% achieved the same stage in the presence of EGF. Similarly, only 16% of the oocytes coming from follicles exposed to hCG þ galardin extruded the first PB, compared to 77% of the oocytes coming from follicles exposed to EGF. The GVBD and PB rates in the in vitro control (hCG plus EGF without galardin) were 94% and 83%, respectively, at 16 h after stimulus.
Similarly, data on meiotic resumption for the group treated with hCG plus AG1478 is only shown for evaluations done at 8, 12, and 16 h. By 8 h, the GVBD rate was 40%, which did not increase significantly later. Therefore, by 16 h, 47% of oocytes reinitiated meiosis (GVBD stage), and the PB rate was 44% (Fig. 3C ).
Gene Expression in Cumulus Cells Before and After Ovulatory Stimulation of Cultured Follicles
Before administering the ovulatory stimulus, transcript levels of Egfr, Has2, and Adamts1 were comparable between the in vitro control and the in vivo control (48 h post-eCG, prehCG). However, levels of Ereg, Cyp19a1, and Hsd3b1 were significantly higher in the in vitro-grown follicles (;6.0-, 4.4-, and 8.8-fold, respectively) than the in vivo controls.
Preovulatory phase (time, 0, 2, 4, and 8 h after stimulus). The gene expression patterns (Fig. 4) at 2, 4, and 8 h were mostly similar in both treated groups (hCG þ galardin and hCG þ galardin þ EGF), with transcripts levels of Ereg, Cyp19a1, and Adamts1 peaking at 2 h and Has2 peaking at 4 h. At 2 h after stimulation, Ereg increased approximately 700-fold above the basal level, then decreased and was subsequently maintained at a low level; however, by 8 h, Ereg   FIG. 1 . Experimental design. Experiments make use of mouse ovarian follicles cultured under a standardized culture system. In vitro-cultured (culture time, 12 days), fully grown follicles were triggered for ovulation by administering different stimuli: control (hCG plus EGF) and two experimental conditions (hCG þ galardin or hCG þ galardin þ EGF). At specified time points, mucification and expansion of cumulus cells and the oocyte meiotic resumption were assessed; and freed cumulus cells were pooled and snap-frozen for gene expression analysis as described in Materials and Methods. The control condition (hCG plus EGF) was only assessed at 0 and 16 h. In addition, cumulus cells from a standard in vivo control were also collected at comparable time points: 48 h after eCG injection and 14 h later, after hCG injection. Postovulatory phase (time, 12 and 16 h after stimulation). Overall, Egfr was decreased and maintained at lower levels in the presence of hCG þ galardin þ EGF. In the absence of EGF, Egfr was increased at 12 and 16 h (;2-and 3-fold, respectively, above the hCG þ galardin þ EGF-treated group). At 12 h, under exogenous EGF, cumulus cells expressed significantly more Ereg compared to the group without EGF (;2-fold). When EGF was not present in the stimulation medium, Cyp19a1 transcript levels rose by 12 and 16 h. Also, levels of Hsd3b1 were lower in the presence of EGF. Omission of EGF from stimulation increased the mRNA levels by 12 and 16 h. Adamts1 and Has2 were not significantly different between treatments and peaked at 2 and 4 h, respectively.
Analysis of gene expression at 16 h revealed that transcript levels of all genes analyzed in cumulus cells of follicles stimulated with hCG þ galardin þ EGF were comparable to those in the in vitro control without galardin and the in vivo control (14 h post-hCG); however, levels of transcripts for Egfr, Has2, Cyp19a1, and Hsd3b1 after 16 h of stimulation with hCG þ galardin were all significantly higher.
Additionally, when AG1478 was used as an inhibitor of the EGF signaling, the expression patterns for Has2 and Cyp19a1 were identical to those obtained by blocking the shedding of the EGF-like factors with galardin.
DISCUSSION
Cumulus cells maintain a close relationship with the oocyte and play an important role during acquisition of oocyte competence [5, 26] . In comparison to mural granulosa cells, cumulus cells are characterized by the ability to expand and mucify during the ovulatory process and by being less steroidogenic [1] [2] [3] [4] . The present study evaluated the response of mouse ovarian follicles cultured in vitro to the ovulatory activation of the LH receptor and the subsequent activation (or omission) of the EGF signaling cascade by measuring the progression in time of oocyte meiotic resumption and gene expression profile in cumulus cells before and during the ovulatory process.
The cumulus cells of follicles grown under in vitro conditions comparable to those in the present study were shown to express low levels of Lhcgr [22] . During culture, mouse granulosa cumulus cells could express variable Lhcgr levels depending on composition of the culture medium and the presence and amount of FSH [22, 27] . Similarly, the in vitro conditions might have made cumulus cells from our follicle culture model prone to elevated basal levels of Hsd3b1 and Cyp19a1.
In the present study, in vitro-cultured, fully grown mouse ovarian follicles received two types of stimuli (hCG þ galardin or hCG þ galardin þ EGF) to induce the final oocyte maturation and follicular luteinizing differentiation. It is known that LH action on ovarian follicles is mediated by the production and release of EGF-like factors and further signaling via the EGF cascade. When activation of the EGF cascade was blocked by addition of an inhibitor of the shedding of endogenously produced EGF-like factors, only half of the oocytes reinitiated meiosis, and only 16% reached the metaphase II stage. Although blockage of the EGF signaling cascade has been shown to limit oocyte meiotic resumption [8, 9, 28] , we have previously demonstrated that EGF or epiregulin alone, administered to in 
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vitro-grown follicles or isolated COCs, has only a limited stimulatory effect on oocyte meiotic resumption [15] . The present results emphasize the important role of the EGF pathway on oocyte meiotic reinitiation and the tight interaction of both LHCGR and EGFR signaling; this interaction has been previously described [29, 30] . It has also been shown that shortly after the LH surge, early phosphorylation of EGFR occurs. This rapid response has been explained by EGFR transactivation via LHCGR. Within a mature follicle, the LH signal might induce immediate release of already-existing, membrane-bound EGF-like factors, followed by phosphorylation of mitogen-activated protein kinase 3/1 [18, 28, 30] . A mechanism for this process has been previously proposed by others [31, 32] .
Although shedding of the EGF-like factors was prevented by a general inhibitor for metalloproteases (galardin), membrane-bound EGF-like factors, produced by LH-responsive cumulus cells, might still be able to signal to the neighboring cells. The juxtacrine signaling via the EGFR has been previously demonstrated in other tissues [33] [34] [35] . Nevertheless, this kind of spatially restricted signal was clearly insufficient to provoke full oocyte meiotic resumption.
The regulation of progesterone production during luteinization has been attributed to EGF signaling [17, 36] . Furthermore, in mammals, activation of progesterone receptor has been suggested as a mediator of oocyte meiotic resumption [17] . The present experiments, using galardin as a blocker of the shedding of EGF-like factors, allowed normal progesterone production (increasing from a basal level of ;2 to ;200 lg/L), suggesting that EGFR signaling is not the main pathway for progesterone production within the cultured follicle. These results are in accordance to those of previous studies in which addition of EGF or epiregulin to intact, in vitro-cultured, fully grown follicles or isolated COCs failed to induce progesterone production [15, 37] .
Analysis of gene expression in cumulus cells of in vitrogrown follicles made clear that both stimulatory treatments (hCG þ galardin and hCG þ galardin þ EGF) induced similar gene expression dynamics during the first 8 h of stimulation. However, gene expression profile between 8 and 16 h suggested that EGF supplementation to follicles treated with hCG þ galardin prevented cumulus cells from acquiring the pattern observed after blocking the EGF signaling (hCG þ galardin). This is supported by the fact that by 16 h, the transcript levels induced by hCG þ galardin þ EGF were identical to those of the in vitro control (hCG plus EGF without galardin) and to those of the in vivo control.
The Ereg mRNA expression pattern in the hCG þ galardintreated group suggests that cumulus cells express functional Lhcgr, which makes them responsive to hCG. Furthermore, Has2 mRNA peaked 2 h after the Ereg peak, displaying the classical cascade events leading to cumulus cell mucification [10] . A similar expression pattern for Has2 has been observed by another study using in vivo-primed mice [38] .
To gain insight regarding the dynamics of Egfr mRNA after the meiotic stimulus, its expression was also assessed. Results suggest that the presence of EGF down-regulates Egfr expression and maintains it at low levels. Because the presence of EGFR in in vivo-and in vitro-cultured rat granulosa cells has been previously shown to be influenced by LH/hCG [39] , the Egfr down-regulation within the ovulatory follicle is most likely induced by the endogenously produced EGF-like factors, acting as second messengers for the LH signal. Expression of Adamts1 mRNA, a matrix metalloproteinase required for ovulation, is induced by progesterone increase [40] [41] [42] ; this suggests the presence of progesterone receptors in cumulus cells, which are most likely activated by progesterone produced by mural granulosa cells as early as 2 h after stimulation of the LH receptor. Progesterone receptor has been found to be highly present in granulosa cells and mildly present in cumulus cells of mouse ovarian follicles cultured for 12 days (unpublished data from our group).
Similar to the expression of epiregulin in cumulus cells induced by activation of the LH receptor, the effect on the transcription of enzymes related to the steroidogenesis pathway (Cyp19a1 and Hsd3b1) was also analyzed. Presence of EGF limited the expression of both transcripts, maintaining their expression at lower levels, close to in vivo levels (at 16 h).
Because both the juxtacrine signaling and EGFR transactivation might partially explain the moderate mucification/ expansion of cumulus cells and the expression pattern observed in the hCG þ galardin-treated group, an extra experiment aimed to block the EGFR activation and also investigate a possible direct effect via the LH receptor. Data from this experiment show that in spite of blocking the EGF signaling (either by galardin or AG1478), the cumulus cells display signs of ovulatory response at both the physiological and the gene expression level. These results provide further evidence that cumulus cells from in vitro-grown follicles have a different phenotype than in vivo-cultured follicles and do respond to LH stimulus. Conversely, the fact that Has2 transcript is produced by cumulus cells of the three conditions, in spite of the presence of galardin or AG1478, might imply that signaling via the EGFR is still active.
The present findings confirm that cultured follicles produce COCs with somewhat different features from in vivo follicles. Their expression pattern during the ovulatory period might therefore be altered to an extent that does not prohibit production of normal offspring [43] [44] [45] . Nonetheless, with the potential application of follicle culture systems as a tool to restore fertility in patients cured of cancer, a precise   FIG. 3 . Gene expression in cumulus cells and oocyte meiotic resumption after ovulatory stimulus with hCG in the presence of AG1478. For comparisons of transcript levels of Has2 (A) and Cyp19a1 (B), the differences between time points were assessed by one-way ANOVA. Each box represents six pools of cumulus cells (obtained from four to eight follicles). Results are presented as relative expression compared to the amount of 18S ribosomal RNA. Different letters above each box indicates significant differences. Results of oocyte meiotic resumption at 8, 12, and 16 h are also displayed (C). P , 0.01.
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understanding of the regulatory mechanisms leading to a competent oocyte under in vitro conditions are of potential use [46] [47] [48] .
In summary, besides the physiological role as second messenger in the LH-induced cascade of ovulation, current results suggest that the EGF signaling during ovulation plays a role in protecting the cumulus cells from the luteinizing effects of LH in an in vitro mouse model for ovarian follicle culture.
